An interventional study of Cytocam-IDF imaging device in Surgery--Complications, sponsored by Universitair Ziekenhuis Brussel. Withdrawn at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-12.
Sponsored by Universitair Ziekenhuis Brussel · Not applicable, Interventional, and Other
The aim of the study is to determine whether there is a correlation between the microcirculation measured preoperatively in patients undergoing major vascular surgery and the postoperative mortality during hospitalization period. The microcirculation will be measured sublingually with the Cytocam-IDF imaging technique.
Universitair Ziekenhuis Brussel is the lead sponsor of 374 studies on the registry; 106 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age ≥ 18 years
Exclusion Criteria:
Emergency surgery
All patients will undergo the same interventional test.
Other: Cytocam-IDF imaging device
Observation of the microcirculation
Postoperative high-sensitive troponin T (hsTnT)
Indicator of acute coronary syndrome
Time frame: 30 days
Cause of death
Causes of death
Time frame: 30 days
Non-cardiovascular adverse events and serious adverse events
Incidence of non-cardiovascular complications
Time frame: 30 days
Cardiovascular adverse events and serious adverse events
Incidence of cardiovascular complications
Time frame: 30 days
Correlation between preoperative microcirculation and postoperative outcome during the hospitalization period.
In addition, demographic parameters (age, weight, height) and comorbidities will be taken into account.
Time frame: 30
Plan to share: Undecided — Presentations of both the study protocol and the study results will be held at conferences. After completion of the study and analysis of the data results will be made publicly without re striction, independent of the outcome. They will be submitted for publication to an international peer-reviewed journal.
No publications or documents are linked to this record.
Start is estimated for Feb 2021; primary completion for Dec 2021, 10 months later.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitair Ziekenhuis Brussel →